Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company

×
watch
Synergy Pharmaceuticals, Inc.

Synergy Pharmaceuticals, Inc.

Sector: Commercial Physical And Biological Research Region: NY, United States

: | Nasdaq: SGYPW | Nasdaq: SGYPU | Nasdaq: SGYP

Listed in: Healthcare & Pharmaceuticals

Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

♣ View Investor Kit View Contact Details

You may also be interested in:

Exelixis, Inc.

South San Francisco, CA, US

Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical product discovery and...

Advanced Cell Technology, Inc.

Marlborough, MA, US

Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases...

Medivir AB

Stockholm, SE

Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products...